The present study demonstrated that bicistronic DNA vaccines encoding gD fused antigens could enhance the induction of antigen-specific cytotoxic CD8+ T cell responses and confer protective immunity to virus infection and therapeutic control of tumor growth. The gene discussed is CD8A; the disease is neoplasm.